ATE110565T1 - Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. - Google Patents
Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.Info
- Publication number
- ATE110565T1 ATE110565T1 AT90915877T AT90915877T ATE110565T1 AT E110565 T1 ATE110565 T1 AT E110565T1 AT 90915877 T AT90915877 T AT 90915877T AT 90915877 T AT90915877 T AT 90915877T AT E110565 T1 ATE110565 T1 AT E110565T1
- Authority
- AT
- Austria
- Prior art keywords
- spin
- trapping
- administration
- methods
- oxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Addiction (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/422,651 US5025032A (en) | 1989-10-17 | 1989-10-17 | Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage |
US58917790A | 1990-09-27 | 1990-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE110565T1 true ATE110565T1 (de) | 1994-09-15 |
Family
ID=27025701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90915877T ATE110565T1 (de) | 1989-10-17 | 1990-10-17 | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. |
Country Status (12)
Country | Link |
---|---|
US (4) | US5405874A (de) |
EP (1) | EP0496796B1 (de) |
JP (5) | JP2620413B2 (de) |
KR (1) | KR960008230B1 (de) |
AT (1) | ATE110565T1 (de) |
AU (4) | AU653921B2 (de) |
CA (1) | CA2069961C (de) |
DE (1) | DE69012138T2 (de) |
DK (1) | DK0496796T3 (de) |
ES (1) | ES2044829T3 (de) |
HK (1) | HK1007281A1 (de) |
WO (1) | WO1991005552A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681845A (en) * | 1989-10-17 | 1997-10-28 | Oklahoma Medical Research Foundation | DMPO spin trapping compositions and methods of use thereof |
EP0496796B1 (de) * | 1989-10-17 | 1994-08-31 | Oklahoma Medical Research Foundation | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten |
US6002001A (en) | 1991-06-18 | 1999-12-14 | Oklahoma Medical Research Foundation | Spin trapping pharmaceutical compositions and methods for use thereof |
ATE209908T1 (de) * | 1991-06-18 | 2001-12-15 | Oklahoma Med Res Found | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN |
US20050107366A1 (en) * | 1991-06-18 | 2005-05-19 | Carney John M. | Spin trapping pharmaceutical compositions and methods for use thereof |
US5292746A (en) * | 1991-09-12 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock |
NZ244268A (en) * | 1991-09-12 | 1994-09-27 | Merrell Pharma Inc | N-oxide quinoline derivatives and pharmaceutical compositions |
JPH0656669A (ja) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | 活性酸素消去作用を持つプテリン誘導体製剤 |
EP0675892A1 (de) * | 1993-10-25 | 1995-10-11 | Oklahoma Medical Research Foundation | Neue phosphor-enthaltende radikalfänger-zusammensetzungen |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
FR2731428B1 (fr) * | 1995-03-06 | 1997-06-06 | Centre Nat Rech Scient | Derives phosphoryles de nitrones, leur procede de preparation et compositions les contenant |
DE69625701T2 (de) * | 1995-09-11 | 2003-10-02 | Aventis Pharma Inc | Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten |
EP0888290B1 (de) | 1995-11-17 | 2006-12-27 | Florida International University | Azulenylnitrone als radikal fanger (spin trapping agents), verfahren zu ihrer herstellung und ihre anwendung |
NZ332315A (en) * | 1996-04-17 | 2000-03-27 | Centaur Pharmaceuticals Inc | Nitrone free radical trapping compounds and their use in the treatment of dementia associated with aids virus (HIV-1) infection |
ATE263559T1 (de) * | 1996-04-23 | 2004-04-15 | Centaur Pharmaceuticals Inc | Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis |
US5900227A (en) * | 1996-06-17 | 1999-05-04 | Oklahoma Medical Research Foundation | Multicyclic nitrone spin trapping compositions |
EP1021430A1 (de) * | 1996-07-19 | 2000-07-26 | Centaur Pharmaceuticals, Inc. | Furan-nitronverbindungen |
TW429241B (en) * | 1996-09-26 | 2001-04-11 | Sumitomo Pharma | Nitrone derivatives |
MA26553A1 (fr) | 1997-10-17 | 2004-12-20 | Centaur Pharmaceuticals Inc | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la |
DE69904018D1 (en) * | 1998-01-16 | 2003-01-02 | Centaur Pharmaceuticals Inc | Thiophennitronderivate |
ZA99252B (en) * | 1998-01-16 | 1999-07-14 | Centaur Pharmaceuticals Inc | Thioether furan nitrone compounds. |
CA2337850A1 (en) | 1998-07-17 | 2000-01-27 | Centaur Pharmaceuticals, Inc. | Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
US6730700B2 (en) | 1998-12-02 | 2004-05-04 | Renovis, Inc. | 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same |
UA66401C2 (en) * | 1998-12-02 | 2004-05-17 | Sentor Pharmaceuticals Inc | 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same |
WO2000074672A1 (en) * | 1999-06-09 | 2000-12-14 | Department Of The Army, U.S. Government | Method and compositions for treating and preventing retinal damage |
CA2404291A1 (en) * | 2000-03-30 | 2001-10-11 | Oklahoma Medical Research Foundation | Butylnitrone containing compositons for inhibition of cancer development |
SE0001916D0 (sv) * | 2000-05-23 | 2000-05-23 | Astrazeneca Ab | Novel formulation |
AU2002253857A1 (en) | 2001-01-08 | 2002-09-04 | Centaur Pharmaceuticals, Inc. | Use of aryl nitrone compounds in methods for treating neuropathic pain |
US20030045461A1 (en) * | 2001-09-06 | 2003-03-06 | Jen-Chang Hsia | Composition and methods of esterified nitroxides gated with carboxylic acids |
FR2846968B1 (fr) * | 2002-11-08 | 2005-02-04 | Salles Jean Pierre | Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert- butyl nitrone |
US6762322B1 (en) * | 2002-12-20 | 2004-07-13 | Goodyear Tire & Rubber Company | Preparation of nitrone derivatives |
US20050059638A1 (en) * | 2003-08-04 | 2005-03-17 | Kelly Michael G. | Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
US20050182060A1 (en) * | 2004-02-13 | 2005-08-18 | Kelly Michael G. | 2-Substituted and 4-substituted aryl nitrone compounds |
US20060235370A1 (en) * | 2005-04-04 | 2006-10-19 | Oblong John E | Method of regulating mammalian keratinous tissue |
US7125934B1 (en) | 2005-06-28 | 2006-10-24 | The Goodyear Tire & Rubber Company | Functionalization of living rubbery polymers with nitrones |
WO2008013866A2 (en) * | 2006-07-25 | 2008-01-31 | Hough Ear Institute | Methods for treating acute acoustic trauma |
US8227517B2 (en) | 2008-02-12 | 2012-07-24 | Tosk, Incorporated | Doxorubicin adjuvants to reduce toxicity and methods for using the same |
JP5253494B2 (ja) * | 2008-03-07 | 2013-07-31 | 国立大学法人 熊本大学 | 電子スピン共鳴測定用試料溶液及びその乾固物,並びにそれらを用いた測定方法 |
WO2010123917A1 (en) * | 2009-04-20 | 2010-10-28 | Volvo Construction Equipment Ab | Integrated paving system and method |
US9034926B2 (en) | 2010-12-30 | 2015-05-19 | Nicholas V. Perricone | Topical nitrone spin trap compositions for psoriasis |
US8986739B2 (en) | 2011-02-28 | 2015-03-24 | Nicholas V. Perricone | Treatment of urinary incontinence using nitrone spin traps |
ES2395803B1 (es) * | 2011-08-01 | 2013-12-19 | Consejo Superior De Investigaciones Científicas (Csic) - 80% | Quinolilnitronas |
DE102011088787A1 (de) | 2011-12-16 | 2013-06-20 | Evonik Industries Ag | Siloxannitrone und deren Anwendung |
WO2022169642A1 (en) * | 2021-02-08 | 2022-08-11 | Oklahoma Medical Research Foundation | Okn-007 as a therapeutic agent for neurodegenerative diseases |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE273702C (de) * | ||||
US35213A (en) * | 1862-05-13 | Improved hydrant | ||
US35112A (en) * | 1862-04-29 | Improvement in head-rests for car-seats | ||
US3396027A (en) * | 1964-05-13 | 1968-08-06 | Eastman Kodak Co | Method of noodling gelatin dispersions |
US3365296A (en) | 1964-05-18 | 1968-01-23 | Gen Aniline & Film Corp | Light-sensitive ultraviolet absorbing compounds and diazotype materials containing the same |
US3296145A (en) * | 1965-10-21 | 1967-01-03 | Millmaster Onyx Corp | Quaternary ammonium-tertiary amine oxide compositions |
US3775122A (en) * | 1967-07-28 | 1973-11-27 | American Can Co | Image production using photosensitive compositions of nitrone which is heat developed |
US3834073A (en) * | 1971-05-03 | 1974-09-10 | Scm Corp | Phenyl nitrone derivatives useful as seed protectants |
US3767818A (en) * | 1971-05-03 | 1973-10-23 | Scm Corp | Phenyl nitrone containing compositions useful as anti microbial agents |
US3849934A (en) * | 1971-05-03 | 1974-11-26 | Scm Corp | Alpha-aryl-n-lower alkyl nitrone-containing compositions useful as anti-fungal agents |
GB1531278A (en) * | 1975-12-15 | 1978-11-08 | Shionogi & Co | 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof |
GB1588417A (en) * | 1977-03-15 | 1981-04-23 | Agfa Gevaert | Photoresist materials |
US4153722A (en) * | 1977-10-06 | 1979-05-08 | William H. Rorer, Inc. | Method of treatment |
US4224340A (en) * | 1977-10-06 | 1980-09-23 | William H. Rorer, Inc. | Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds |
US4197314A (en) * | 1977-10-06 | 1980-04-08 | William H. Rorer, Inc. | Method of treating inflammation |
US4214003A (en) * | 1977-10-06 | 1980-07-22 | William H. Rorer, Inc. | Method of treatment |
US4870002A (en) * | 1981-04-07 | 1989-09-26 | The United States Of America As Represented By The Secretary Of The Air Force | Method of prevention of oxidative injury to cells |
WO1988005044A1 (en) * | 1986-12-29 | 1988-07-14 | Pharmacia Ab | Nitroxide compounds for the preparation of a pharmaceutical composition intended for the prophylaxis and treatment of ischemic cell damage |
AU1362488A (en) * | 1987-01-28 | 1988-08-24 | Peter H. Proctor | Topical composition and method for stimulating hair growth with stable free radicals |
US5025032A (en) * | 1989-10-17 | 1991-06-18 | Oklahoma Medical Research Foundation | Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage |
EP0496796B1 (de) * | 1989-10-17 | 1994-08-31 | Oklahoma Medical Research Foundation | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten |
US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
-
1990
- 1990-10-17 EP EP90915877A patent/EP0496796B1/de not_active Expired - Lifetime
- 1990-10-17 KR KR1019920700900A patent/KR960008230B1/ko not_active IP Right Cessation
- 1990-10-17 JP JP2515036A patent/JP2620413B2/ja not_active Expired - Fee Related
- 1990-10-17 DE DE69012138T patent/DE69012138T2/de not_active Expired - Fee Related
- 1990-10-17 ES ES90915877T patent/ES2044829T3/es not_active Expired - Lifetime
- 1990-10-17 DK DK90915877.6T patent/DK0496796T3/da active
- 1990-10-17 WO PCT/US1990/005952 patent/WO1991005552A1/en active IP Right Grant
- 1990-10-17 AT AT90915877T patent/ATE110565T1/de not_active IP Right Cessation
- 1990-10-17 CA CA002069961A patent/CA2069961C/en not_active Expired - Fee Related
- 1990-10-17 AU AU66133/90A patent/AU653921B2/en not_active Ceased
-
1993
- 1993-03-05 US US08/027,559 patent/US5405874A/en not_active Expired - Lifetime
-
1994
- 1994-12-28 US US08/365,548 patent/US5578617A/en not_active Expired - Fee Related
-
1995
- 1995-01-20 AU AU11315/95A patent/AU692197B2/en not_active Ceased
- 1995-06-06 US US08/468,561 patent/US5681965A/en not_active Expired - Fee Related
- 1995-06-06 US US08/468,563 patent/US6107315A/en not_active Expired - Fee Related
-
1996
- 1996-07-09 JP JP8179709A patent/JP2816326B2/ja not_active Expired - Fee Related
-
1998
- 1998-03-25 JP JP10077985A patent/JPH10259128A/ja active Pending
- 1998-03-25 JP JP10077984A patent/JP2975587B2/ja not_active Expired - Fee Related
- 1998-06-24 HK HK98106466A patent/HK1007281A1/xx not_active IP Right Cessation
- 1998-09-04 AU AU83101/98A patent/AU710341B2/en not_active Ceased
- 1998-09-04 AU AU83102/98A patent/AU710342B2/en not_active Ceased
-
2001
- 2001-11-08 JP JP2001343709A patent/JP2002179563A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU692197B2 (en) | 1998-06-04 |
AU653921B2 (en) | 1994-10-20 |
JPH10259178A (ja) | 1998-09-29 |
KR920702220A (ko) | 1992-09-03 |
US5405874A (en) | 1995-04-11 |
AU6613390A (en) | 1991-05-16 |
JP2816326B2 (ja) | 1998-10-27 |
AU8310298A (en) | 1998-10-22 |
JPH10259128A (ja) | 1998-09-29 |
AU710342B2 (en) | 1999-09-16 |
US5578617A (en) | 1996-11-26 |
AU8310198A (en) | 1998-12-24 |
JP2620413B2 (ja) | 1997-06-11 |
AU710341B2 (en) | 1999-09-16 |
ES2044829T1 (es) | 1994-01-16 |
JP2002179563A (ja) | 2002-06-26 |
EP0496796B1 (de) | 1994-08-31 |
EP0496796A1 (de) | 1992-08-05 |
HK1007281A1 (en) | 1999-04-09 |
JP2975587B2 (ja) | 1999-11-10 |
JPH0925263A (ja) | 1997-01-28 |
WO1991005552A1 (en) | 1991-05-02 |
US6107315A (en) | 2000-08-22 |
AU1131595A (en) | 1995-03-23 |
DE69012138D1 (de) | 1994-10-06 |
DE69012138T2 (de) | 1995-04-06 |
US5681965A (en) | 1997-10-28 |
ES2044829T3 (es) | 1995-01-16 |
KR960008230B1 (ko) | 1996-06-21 |
DK0496796T3 (da) | 1994-10-03 |
CA2069961A1 (en) | 1991-04-18 |
CA2069961C (en) | 2000-05-02 |
JPH05505792A (ja) | 1993-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE110565T1 (de) | Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten. | |
NO882732L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
DE69805973T2 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase | |
NO884625D0 (no) | N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel. | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
ATA95989A (de) | Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten | |
DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
IL85228A (en) | 1-(4-hydroxy-3,5-di-tert.- butylbenzoyl) homopiperazine, various derivatives thereof, processes for the preparation of these and pharmaceutical compositions containing them | |
DK393188D0 (da) | Farmaceutisk praeparat til intranasal administrering | |
DK122391D0 (da) | Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme | |
ATE282406T1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
DE58904722D1 (de) | Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie. | |
HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
NO893256L (no) | Fremgangsmaate for fremstilling av furyltiazolderivater. | |
DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf | |
ATA77095A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanz | |
DE60024969D1 (de) | 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten | |
ATE6256T1 (de) | N-(4-phenyl-2-thiazolyl)-oxamidsaeure-2ethoxyethylester, verfahren zu seiner herstellung und diesen enthaltende therapeutische mittel. | |
DK0486586T3 (da) | Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem | |
ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
ATE91414T1 (de) | Hustenstillende zusammensetzungen und ein verfahren zu deren herstellung. | |
BR9713982A (pt) | Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, processo de tratamento de um corpo humano ou não humano para controlar infecções bacterianas. | |
IT8723007A0 (it) | Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle | |
ATE92924T1 (de) | Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |